What constraint would you use for front eye/cornea when treating with palliative intent?
In conventional fractionation of two gray or less, maximum front eye/cornea doses of 30–35 gray have been recommended (DAHANCA) to limit risk of conjunctivitis and dry eye syndrome. What would you counsel on the risk of corneal ulceration with a hypofractionated palliative regimen?